Funds will support NANT 2013-02 Phase I Study of Sorafenib with Cyclophosphamide and Topotecan in Patients with Relapsed and Refractory Neuroblastoma.
New Approaches to Neuroblastoma Therapy (NANT)
Soupy for Loopy is no longer participating in this program. Thank you for your support !
The trial supported by the Soupy for Loopy Foundation will use bevacizumab (AvastinTM) and zoledronic acid (Zometa®) with low doses of the chemotherapeutic agent cyclophosphamide (cytoxan). Referred as N0702,
Copyright 2007-2018 Soupy for Loopy Foundation, Inc. All rights reserved.